The latest closing stock price for NeuBase Therapeutics as of June 06, 2024 is 0.38.
An investor who bought $1,000 worth of NeuBase Therapeutics stock at the IPO in 2007 would have $-1,000 today, roughly -1 times their original investment - a -39.78% compound annual growth rate over 17 years.
The all-time high NeuBase Therapeutics stock closing price was 7860.00 on March 14, 2014.
The NeuBase Therapeutics 52-week high stock price is 1.51, which is 297.4% above the current share price.
The NeuBase Therapeutics 52-week low stock price is 0.36, which is 5.3% below the current share price.
The average NeuBase Therapeutics stock price for the last 52 weeks is 0.66.
An investor who bought $1,000 worth of NeuBase Therapeutics stock at the IPO in 2007 would have $-1,000 today, roughly -1 times their original investment - a -39.78% compound annual growth rate over 17 years.
The all-time high NeuBase Therapeutics stock closing price was 7860.00 on March 14, 2014.
The NeuBase Therapeutics 52-week high stock price is 1.51, which is 297.4% above the current share price.
The NeuBase Therapeutics 52-week low stock price is 0.36, which is 5.3% below the current share price.
The average NeuBase Therapeutics stock price for the last 52 weeks is 0.66.